Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
Related Posts
Softbank CEO Masayoshi Son to announce $100 billion investment in U.S. during visit with Trump
Post Content
Data centers powering artificial intelligence could use more electricity than entire cities
The growing size of data centers is raising questions about power, land and the environment.
Kyruus builds a generative AI provider matching solution on AWS
This post was written with Zach Heath of Kyruus Health. When health plan members need care, they shouldn’t need a…